DropGenie Lands $5M Seed+ to Scale Gene-Editing in Scarce Patient Cells

DropGenie raised $5M in Seed+ funding from BDC Thrive, Skeleton Key, Merck's GHI Fund and others to scale a gene-editing platform that uses up to 100x fewer patient cells.